Clinical trial
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With…
NCT00312026 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00312026 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet |
| Official title | A Phase IV Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 1.0 mg/kg Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis Involving the Hands and/or Feet |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | efalizumab |
| Enrollment | 75 |
| Start date | Mar 30, 2006 |
| Primary completion | Nov 28, 2006 |
| Completion | Nov 28, 2006 |
| First posted | Apr 7, 2006 |
| Last update posted | Feb 15, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: